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Filament assembly of nonmuscle myosin IIA (NMIIA)
is selectively regulated by the small Ca2+-binding
protein, S100A4, which causes enhanced cell migra-
tion and metastasis in certain cancers. Our NMR
structure shows that an S100A4 dimer binds to a
single myosin heavy chain in an asymmetrical con-
figuration. NMIIA in the complex forms a continuous
helix that stretches across the surface of S100A4 and
engages the Ca2+-dependent binding sites of each
subunit in the dimer. Synergy between these sites
leads to a very tight association (KD 1 nM) that is
unique in the S100 family. Single-residue mutations
that remove this synergy weaken binding and
ameliorate the effects of S100A4 on NMIIA filament
assembly and cell spreading in A431 human epithe-
lial carcinoma cells. We propose a model for NMIIA
filament disassembly by S100A4 in which initial
binding to the unstructured NMIIA tail initiates unzip-
ping of the coiled coil and disruption of filament
packing.
INTRODUCTION
Many fundamental processes in cells such as adhesion, migra-
tion, and proliferation are force dependent. Maintenance of cell
polarity and cell-cell and cell-matrix contacts requires con-
tinuous tension. In migrating cells, adhesion complexes are
established under the influence of tension and coordinate trac-
tion for cell propulsion. The intracellular force is generated by
nonmuscle myosin II (NMII), which is ubiquitously expressed in654 Structure 20, 654–666, April 4, 2012 ª2012 Elsevier Ltd All rightseukaryotic cells (Vicente-Manzanares et al., 2009). NMII has
two main isoforms, NMIIA and NMIIB, with distinctly different
properties. Recent studies in several cell lines, such as CHO-
K1, COS-7, and B16, showed that NMIIA is more dynamic and
is involved in the initial adhesion stages at the leading edge
of the cell, as well as the force-controlled disassembly of the
adhesion complexes at the trailing edge. In contrast, NMIIB is
mainly localized in the central zones and the cell rear, where it
generates persistent tension required for the maintenance of
stable adhesions (Vicente-Manzanares et al., 2007).
The differences in the localization of the NMII isoforms in CHO-
K1, COS-7, and B16 cells are associated with the C-terminal
coiled-coil region (Vicente-Manzanares et al., 2008). This region
is required for the formation of the bipolar myosin filaments
that bundle actin into stress fibers and generate sliding motion
of the actin filaments. The last 200 residues of the coiled-coil
region contain the assembly competent domain (ACD) that is
involved in the regulation of the filament assembly by phosphor-
ylation. An additional regulatory mechanism is associated with
the small Ca2+-binding protein S100A4 (Garrett et al., 2006;
Tarabykina et al., 2007) that selectively associates with ACD of
NMIIA, but not NMIIB. In vitro, S100A4 binding causes myosin
filaments and rod fragments to dissociate (Ford et al., 1997; Kria-
jevska et al., 2000; Li et al., 2003; Badyal et al., 2011). The level of
S100A4mRNA and protein is upregulated in a range of migrating
cells and in metastases. The role of S100A4 as a metastasis
promoter has been demonstrated in mouse and rat models
(Davies et al., 1993; Ambartsumian et al., 1996; Davies et al.,
1996). It is important to note that many cell types do not have
a clear separation of NMIIA and NMIIB distribution and activities
as the analyzed CHO-K1, COS-7, and B16 cell lines. This
suggests that S100A4 may play a prominent role only in certain
unmodified or transformed cell types.
S100A4 belongs to a large family of dimeric EF-hand calcium-
binding proteins (Santamaria-Kisiel et al., 2006). Similar to otherreserved
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Structure of Ca2+-S100A4/Myosin IIA ComplexS100 proteins, Ca2+ binding induces a conformational switch
that exposes a binding site in the cleft between helices H3
and H4 of the C-terminal EF hand in each of the subunits of
the S100A4 dimer. Although the structures of the apo- and
Ca2+-bound forms have been solved (Vallely et al., 2002; Gingras
et al., 2008; Malashkevich et al., 2008), the structure of the
S100A4/NMIIA complex remained elusive. In the absence of
direct structural information, conclusions on the size and loca-
tion of the binding site have been drawn from binding studies
that involved a range of myosin fragments. Myosin peptides
containing as few as 15 residues were reported to bind to
S100A4 with micromolar affinity that is compatible with a site
involving a single EF-hand cleft (Malashkevich et al., 2008).
However, these results were influenced by the use of the fluores-
cent label that interacts with S100A4 and directly contributes to
the binding (Badyal et al., 2011).
Here, using unmodified myosin fragments, we have identified
the full binding region of S100A4 in myosin and have solved
the structure of the complex. We demonstrate that both Ca2+-
dependent sites of the S100A4 dimer contribute to the binding
of a single NMIIA heavy chain resulting in an asymmetrical 1:2
NMIIA/S100A4 complex with nanomolar affinity. Using the struc-
ture of the complex, we designed mutations that interfere with
the coupling between the binding sites, while leaving the EF2-
hand clefts unmodified. The mutations dramatically reduce the
affinity, demonstrating the dominant role of synergy between
the two EF2-hand sites of the S100A4 dimer in the binding
mechanism. Using the same S100A4 mutants, we demonstrate
a direct effect of S100A4 on cell migration, cell spreading, and
assembly of myosin filaments. Electronmicroscopy (EM) directly
shows the association of a myosin coiled-coil fragment with
two S100A4 dimers, in agreement with the 1:2 NMIIA:S100A4
stoichiometry.
RESULTS
Mapping the S100A4-Binding Site on NM-MHC IIA
The extent of the S100A4-binding site in NMIIA has been contro-
versial (Kriajevska et al., 1998; Malashkevich et al., 2008; Badyal
et al., 2011). Recently, we used NMR to demonstrate that the
unstructured region F1926–A1939 that immediately follows the
coiled-coil region is essential for the interaction with S100A4
(Badyal et al., 2011). However, the large size of the myosin frag-
ment M111 (residues Q1850–E1960) used in the analysis did not
allow us to determine the N-terminal boundary of the binding site
because signals of the residues from the coiled-coil region were
not observed (Badyal et al., 2011). Based on these previous data,
we reduced the size of the fragment by removing the residues
not in contact with S100A4 (Figure 1A), generating an M70 frag-
ment (residues A1868–G1938).
The 1H,15N-HSQC spectrum of M70 at elevated temperature
of 40C corresponds to a highly dynamic random coil state
with uniform intensities for the majority of the cross-peaks
(see Figure S1A available online). The backbone 13C chemical
shift values support this conclusion (Figure S2G). The addition
of S100A4 leads to a dramatic increase of the chemical shift
dispersion and broadening of the cross-peaks in a continuous
region E1899–R1933 (Figures 1B and S1A). This signifies direct
contact of this region with S100A4 and identifies it as the bindingStructure 20site. Based on this mapping, we investigated a peptide, M39
(residues Q1897–A1935), that has two residue extensions at
the N and C termini of the S100A4-interacting region. Both
M70 and M39 induce changes in the 1H,15N-HSQC spectra of
Ca2+-bound S100A4 (Figure S1B), confirming the similarity of
the interactions for the two fragments.
Unexpectedly, for approximately half of the residues, two
HSQC peaks with distinctly different chemical shifts are ob-
served for the 15N-labeled S100A4 in the complex with unlabeled
myosin, in contrast to one peak per residue detected for the
free protein (Figure 1C). The doubled cross-peaks appear on
the first addition of the peptide and remain at equal relative inten-
sity throughout the S100A4 titration with M39, corresponding to
a slow exchange regime due to the high affinity of the interaction.
The signals of the free form disappear completely when the M39
monomer concentration is above the concentration of the
S100A4 dimer, and no further changes of the S100A4 spectra
are observed. These spectral changes and the concentration
dependence suggest that a single M39 molecule binds to the
S100A4 dimer, resulting in an asymmetrical 1:2 M39/S100A4
complex. In this arrangement, some sequentially identical sites
of the two monomers in the S100A4 dimer would be in contact
with different parts of the peptide, making them structurally
nonequivalent and leading to different chemical shifts.
The similarity between the spectra of S100A4 complexes with
M39 and M70 shows that asymmetric binding is a general
characteristic of S100A4 interaction with myosin. For shorter
myosin fragments, only a single peak was detected for each
S100A4 residue in the complex, although a number of peaks
were severely broadened even at high excess of myosin over
S100A4 (Malashkevich et al., 2008; Badyal et al., 2011). Further-
more, chemical shifts of S100A4 changed gradually on the
myosin peptide addition, demonstrating weaker interaction,
as expected for the incomplete binding region. The residual
broadening of the S100A4 resonances in the complex with
short peptides is likely to be caused by the exchange of the
peptide between equivalent asymmetrical arrangements on the
S100A4 dimer.
Independent direct evidence for the 1:2 stoichiometry of
S100A4 complexes with a myosin fragment was obtained from
multi-angle laser light-scattering experiments (MALLS), coupled
with refractive index and absorbance detection, that provide
absolute molecular weights of proteins independently of their
shape and folding state (Wyatt, 1993). The S100A4/myosin
complex was resolved from the free protein using size-exclusion
chromatography (SEC) in a SEC-MALLS setup, although no
conclusion on the molecular weights was derived from the
elution profiles due to their strong dependence on the shape of
the proteins. For both S100A4/M111 (Figure 1D) and S100A4/
M70 (Figure S2) complexes, uniform distribution of themolecular
weight was observed across the peak of the complex. The
measured molecular weights of 38.3 ± 0.11 kDa and 34.2 ±
0.15 kDa for complexes with M111 and M70, respectively,
were close to the respective values of 40.1 and 34.3 predicted
for the 1:2 S100A4/myosin stoichiometry of these fragments.
The affinity of the interaction was too high to determine the
binding constant from the NMR titration, although it clearly
showed 1:2 stoichiometry. A large enthalpy release on binding
allowed us to record good quality isothermal titration calorimetry, 654–666, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 655
Figure 1. Interaction of S100A4 with NMIIA
(A) Sequence of myosin fragments used in the binding site mapping. M111 corresponds to the whole sequence, M70 is highlighted in blue and red, and M39 in
red. Residues in italic identify the unstructured C-terminal region of myosin. Residues in a and d positions of the heptad repeat that are critical for the coiled-coil
stability are underlined.
(B) Intensities of 1H,15N-HSQC cross-peaks of uniformly 15N-labeled M70 in complex with u-S100A4 normalized on the intensity for the last residue G1938. Low
intensities correspond to the residue immobilized by direct contact with S100A4. M39 location is indicated by the red rectangle
(C) 1H,15N-HSQC spectrum of 15N-labeled S100A4 in the free form (blue) and in the presence of 0.5 mole equivalent of u-M39 (red). Doubling of the cross-peak
demonstrates asymmetric environment for equivalent residues of the S100A4 dimer. Colors of the labels indicate free (blue) and bound (red) forms. Residues are
labeled A, B, or A/B to denote the monomer subunit that gives rise to the signal.
(D) Gel filtration elution profile of the SEC-MALLS experiment for the 1:1 molar ratio used to determine the molecular weight of S100A4/M111 complex. Both the
complex (peak I) and the free form of S100A4 (peak II) are observed. The molecular weight of 39.3 kDa measured for the M111/S100A4 peak is in a very good
agreement with 40.1 kDa expected for the 1:2 complex.
(E) ITC record of S100A4 titration with M39 at 10 mM S100A4 in the cell and 75 mM of M39 in the syringe. The solid line shows the fitting to the single site-binding
model with KD of 4 nM.
See Figure S1 for further binding measurements. See also Table S1.
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Structure of Ca2+-S100A4/Myosin IIA Complex(ITC) data at protein concentrations as low as 10 mM, but even at
these concentrations, the transition between the free and the
bound state was sharp, and the binding isotherm had a small
number of points in the transition region (Figure 1E). A single
binding site model resulted in a good fit with a KD of 5.9 ±
1.3 nM (n = 3) and M39/S100A4 ratio of 0.55 ± 0.06. The stoichi-
ometry of the interaction is well defined and agrees with the NMR
and MALLS measurement. The determined KD, however, is only
an upper-limit value because the number of points in the transi-
tion area is too small for accurate fitting. At least 10-fold reduc-
tion in the protein concentration is required for the accurate
measurement, which is not possible due to the limit of the instru-
ment sensitivity.
To support the ITC measurements, we used the surface
plasmon resonance (SPR) method that can be conducted at
lower concentrations. The titration sensorgrams at nanomolar
concentrations of M39 show a relatively fast association rate
constant and a slow koff. Simultaneous fitting of the sensorgrams
to a single site-binding model results in a KD of 0.24 ± 0.07 nM
(n = 3) (Figure S1H). The NMR, MALLS, and ITC results confirm
earlier indications of the 1:2 stoichiometry for NMIIA/S100A4
complex deduced from the concentration of S100A4 required
to solubilize a M200 (Q1761–E1960) filament (Badyal et al.,
2011). In that work we also showed that an M32 peptide
(A1907-G1938) bound to S100A4 with a KD of 3 mM. Using
similar kinetic assays (Badyal et al., 2011), we determine here
(Figures S1I–S1L) that M39 binds to S100A4 with a KD of
0.1 nM and a koff of z0.001 s1, in line with the SPR studies
above. These data support the notion that the KD determined
by ITC is best viewed as an upper limit, and the true KD
is <1 nM. We, therefore, conclude the KD is %1 nM as a limit
compatible with all methods.
Structure of M39/S100A4 Complex
To determine the structure of the S100A4/NMIIA complex, we
used synthetic unlabeled M39, recombinant unlabeled and
13C,15N-labeled M70, and recombinant unlabeled and 13C,15N-
labeled S100A4 to produce complexes where only one of the
component is isotope labeled for selective detection of reso-
nances from each of the components. The chemical shifts of
S100A4 in both the M39 and M70 complexes, as well as the
shifts of M39 and the corresponding region of M70 are close,
demonstrating structural similarity. This agrees with the lack of
direct contacts from the N-terminal (A1868–Q1897) part of
M70 that are absent in M39 and allows us to combine the data
for the two complexes when solving the structure.
Most of the resonances of the N-terminal pseudo-EF1 hand
region 1–44 of the two subunits of S100A4 dimer in the complex
are close and not resolved in 3D spectra, with an exception of
a small number of resonances primarily of backbone HN groups.
Additionally, the NOEpatterns for the resolved resonances in this
region are very similar, showing that the two subunits have
similar structures in this region. In contrast, the resonances of
the EF2-hand region 45–95 are distinctly different in the two
subunits, indicating possible structural differences. To account
for this, we applied symmetry restraints only for the N-terminal
part. The resonances of the C-terminal region 96–101 are sharp
and identical for both subunits, demonstrating that this part is
unstructured and dynamic.Structure 20The superposition of the lowest-energy structures is shown in
Figure 2A, and the statistics of the structure calculation are
summarized in Table 1. Both S100A4 and M39 are well defined
in the calculated structure (backbone rmsd 0.50 and 0.54 A˚
´
,
respectively), corresponding to the large number of the intra-
and intermolecular NOE restraints used. The myosin peptide
forms a helix that is positioned across the EF hands of both
subunits, connecting the two hydrophobic EF2-binding sites
that become exposed on Ca2+ binding to S100A4 (Vallely
et al., 2002; Gingras et al., 2008; Malashkevich et al., 2008)
(Figure 2B). The hydrophobic residues located on one face of
the amphipathic myosin helix (Figure 2C) make extensive
contacts with the surface residues of S100A4. These contacts
are particularly prominent at the hydrophobic pockets between
the helices H3 and H4 (Figures 2B and 2D).
The two EF2 sites interact with the opposite ends of the M39
helix, making them structurally distinct and causing doubling of
the NMRs. For simplicity of description we refer to the sites as
A and B according to their contacts with, respectively, the N-
or C-terminal regions of myosin. At site A the side chain of the
N-terminal L1900 is inserted into a hydrophobic pocket formed
by the side chains of L58, F78, I82, and M85, with additional
contacts from Me groups of A1903 and T1904. At the site B
the same hydrophobic residues of a different S100A4 subunit
make contacts with the side chains of L1921 and L1926 at the
C-terminal part of the M39 helix, as well as F1928 and V1930
from the nonhelical part of the molecule. The C-terminal part of
M39 extends further along the groove between the helices
toward the opposite face of the molecule, making additional
hydrophobic contacts that involve P1931 and M1934. A close
contact between M39 and S100A4 is supported by a large
number of intermolecular NOEs detected in the complex. Fig-
ure S2A illustrates the NOEs for the Me groups of I82 that
show a clear distinction between the contacts at site A and B.
In addition to the hydrophobic contacts, the charged and
polar residues of M39 are optimally positioned for forming
hydrogen bonds and salt bridges with the complementary
S100A4 residues (Figure S2B). At the N terminus of M39,
E1901 and E1905 are close to K57 and N61 of S100A4. In the
mid-region N1911 and R1912 are in proximity to E74, whereas
E1913 is close to N73. At the C-terminal part of the M39 helix,
K1918 is close to N73, R1922 is near E88, and D1925 close to
K57 and N61. The matching charges are likely to contribute to
the energy of the interaction and enhance the selectivity of
S100A4 toward the specific myosin isoform, NMIIA.
In the longer M70 fragment, the NOE pattern and chemical
shift values indicate the formation of an additional helix at the
N terminus (Figures S2E–S2G). No contacts were detected
between this helix and S100A4, in agreement with increased
dynamics in this region (Figure 1B). The N-terminal helix is
separated from the S100A4-binding site by the unstructured
region. The shorter M32 peptide (residues 1,907–1,938) binds
with an affinity of 3 mM, which is sufficiently high to reach satu-
ration at the concentrations used. However, the NMR spectra
show only one set of signals for S100A4 at all peptide concen-
trations (Badyal et al., 2011). Some of these signals remain
broadened even at high excess of M32, indicating exchange
process within the complex. For M32 in the complex, we de-
tected similar intermolecular NOEs as for the corresponding, 654–666, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 657
Figure 2. Structure of M39/S100A4 Complex
(A) Superposition of the backbone atoms for ten lowest-energy structures of M39/S100A4 complex. M39 is shown in orange; subunits of S100A4 dimer are in
green and cyan.
(B) Lowest-energy structure of M39/S100A4 complex in two orientations related by 90 rotation along the vertical axis. The boxed areas indicate sites A and B.
(C) Structure of bound M39. Hydrophobic residues of M39 in direct contact with S100A4 are highlighted in magenta and labeled.
(D) Hydrophobic contacts at site A (left) and B (right). For clarity only the helices H3 and H4 are shown as viewed from the back in the orientation shown in (B).
Helices H3 and H4 are oriented in a similar way for both sites.
(E) Superposition of the M39/S100A4 structure on the structures of (from left to right) TRTK-12/S100B (PDB 3IQQ), TRTK-12/S100A1 (PDB 2KBM), and RyRP12/
S100A1 (PDB 2K2F). M39 is shown in light orange, S100A4 in green and cyan, S100B and S100A1 in gray, and TRTK-12 and RyRP12 in red and magenta. Note
that in contrast to M39/S100A4, each of these complexes is symmetrical and has a 2:2 configuration. Despite this difference, they match some features of the
M39/S100A4 complex. TRTK-12 binding to S100B mostly resembles that of the C-terminal nonhelical portion of M39 and the last turn of the helix. TRTK-12 in
complex with S100A1 aligns well with the N- and C-terminal ends of the M39 helix. The helix of RyRP12 in the complex with S100A1 is longer and extends further
toward the adjacent EF2 site.
See Figure S2 for further structural analysis and comparison with other S100 protein complexes.
Structure
Structure of Ca2+-S100A4/Myosin IIA Complexregion of M39, demonstrating similarity of the interaction.
Modeling of M32 on the structure of M39 complex shows
that the peptide would extend into the second EF2 site and
interfere with binding of the second peptide molecule. At the
same time the peptide is not long enough to interact with658 Structure 20, 654–666, April 4, 2012 ª2012 Elsevier Ltd All rightsboth EF2 sites. As a result one site would either remain unoc-
cupied, or binding of the second molecule would destabilize
the complex. The exchange of the peptide between the sites
enhanced by this self-competition would lead to the observed
resonance broadening. A similar resonance broadening wasreserved
Table 1. NMR and Refinement Statistics for M39/S100A4
Complex
NMR Distance and Dihedral
Constraints M39/S100A4
Distance constraints
Total NOE 7,085
Intra-residue 377 (M39), 2,071 (S100A4)
Inter-residue
Sequential (ji  jj = 1) 389 (M39), 1,634 (S100A4)
Medium range (ji  jj < 4) 326 (M39), 1,356 (S100A4)
Long range (ji  jj > 5) 1,783 (S100A4)
Intermolecular 977
Hydrogen bonds 0
Total dihedral angle restraints
f 156 (S100A4), 26 (M39)
c 156 (S100A4), 26 (M39)
Structure Statistics
Violations (mean ± SD)
Distance constraints (A˚) 0.05 ± 0.004
Dihedral angle constraints () 1.9 ± 0.3
Maximum dihedral angle
violation ()
8
Maximum distance constraint
violation (A˚)
0.5
Deviations from idealized geometry
Bond lengths (A˚) 0.005 ± 0.00014
Bond angles () 0.72 ± 0.017
Impropers () 2.1 ± 0.14
Average rmsd to mean structure (A˚)a
Heavy 0.91
Backbone 0.50
aRmsd was calculated among 20 refined structures.
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Structure of Ca2+-S100A4/Myosin IIA Complexreported for an even shorter peptide 1,908–1,923 (Malashke-
vich et al., 2008).
The conformation of S100A4 in the complex is similar to that of
the Ca2+ form (PDB 3C1V; rmsd 1.6 A˚;, Figure S2C). This demon-
strates a limited effect ofmyosin binding on the S100A4 structure.
Similar overall structure conservation was observed for
complexes of other S100 proteins (Figures 2E and S2D) (Re´ty
et al., 1999; Rustandi et al., 2000; Bhattacharya et al., 2003; Lee
et al., 2008; Wright et al., 2008, 2009; Charpentier et al., 2010).
Simultaneous engagement of both EF2 sites of the S100A4
dimer in the binding of a single myosin molecule in an asymmet-
rical 1:2 configuration is novel for S100 proteins. In all other
reported structures of S100 complexes (Re´ty et al., 1999; Rus-
tandi et al., 2000; Bhattacharya et al., 2003; Lee et al., 2008;
Wright et al., 2008, 2009; Charpentier et al., 2010), the EF2 sites
on each monomer are occupied by independent ligand mole-
cules in a symmetrical 2:2 complex (Figures 2E and S2D).
Involvement of the two EF2 sites in S100A4 dramatically extends
the binding interface, leading to nanomolar affinity not observed
in any other S100 complexes. The location of the EF2-binding
sites on one face of the molecule allows them to accommodate
an uninterrupted long helix.Structure 20Asymmetrical binding has recently been reported for the
interaction of AHNAK with a preformed S100A10/annexin
complex (Rezvanpour et al., 2011). To our knowledge, the struc-
ture of the complex has not been solved yet, but the reported
information suggests that the configuration of the complex is
likely to be different from M39/S100A4. The AHNAK fragment
of 18 residues is too short to link the 2 EF2 sites, and the
NMR-binding site mapping indicates that the interactions are
primarily restricted to the helices H4/H40 of S100A10.
Similar to M39, all other reported S100 ligands adopt helical
structures, although the orientations of the helices differ sig-
nificantly between the complexes (Figure S2D). In most other
ligands the helices are much shorter than M39 and can interact
with only one EF2 site. One exception is SIP interaction with
S100A6 (2JTT; Lee et al., 2008), where the ligand forms two
helices. However, only the N-terminal helix binds to EF2 site,
whereas the C-terminal region interacts with the Ca2+-indepen-
dent site along the helix H1. This leads to a symmetrical 2:2-
binding mode, distinctly different from that of M39/S100A4
complex.
Despite the differences in the overall binding mode, different
regions of the N and C termini of the M39 structure in the
complex with S100A4 superimpose well with the CapZ peptide
(TRTK-12) in complex with S100B (Charpentier et al., 2010)
and S100A1 (Wright et al., 2009) (PDB 3IQQ and 2KBM, respec-
tively), as well as ryanodine (RyRP12) in complex with S100A1
(Wright et al., 2008) (PDB 2K2F), as illustrated in Figure 2E.
This suggests that other S100 proteins may adopt the asymmet-
rical bindingmodewith suitable ligands ormay interact with NMII
with significant affinity.
Effect of S100A4 on NMIIA in Cells
Previous studies of the role of S100A4 in cell lines or animal
models have exploited mutations that affected the Ca2+-binding
properties, the dimerization interface, and C-terminal region
(Kim and Helfman, 2003; Zhang et al., 2005; Ismail et al., 2008,
2010). Modifications of these regions change overall character-
istics of S100A4 and its interactions with all ligands, making
the mutations nonselective. Here, we have used structural infor-
mation to design NMIIA-specific mutants. Despite extensive
contacts (Figure 2), disruption of the S100A4/ NMIIA interaction
while maintaining structural integrity and Ca2+-binding proper-
ties is not straightforward. Many NMIIA-contacting residues
are buried in the apo form of S100A4, and their modification
would destabilize the protein. However, the unique myosin-
binding mode offers an unexpected solution. The middle of the
M39 helix crosses the exposed surfaces of the two equivalent
and antiparallel helices H4/H40 from different subunits (Fig-
ure 3A). As a result, the side chains of V77/V770 and C81/C810
become buried under the hydrophobic surface of the M39 helix
and make extensive hydrophobic interactions: V77 contacts
A1907, M1910, and N1911; V770 contacts E1913, V1914, and
L1917; C81 contacts T1906, A1907, and M1910; and C810
contacts V1914, L1917, and K1918. The change of either of
these residues to Asp in V77D or C81Dmutants would introduce
two negatively charged groups from different subunits under the
myosin hydrophobic surface and destabilize the complex.
In agreement with the prediction, the mutations strongly
reduce the affinity, while having practically no effect on, 654–666, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 659
Figure 3. S100A4 Affects Stress Fibers, Shape, Spreading, and Motility of A431 Cells
(A) Cartoon representation of the M39/S100A4 complex illustrating positions of the mutated residues. The two orientations differ by a 90 rotation along the
horizontal axis. Zoomed region shows contacts of the mutated residues V77 and C81 (side chains are shown as sticks; residues are highlighted in yellow). M39 is
shown in orange; side chains contacting V77 and C81 in the complex are presented as sticks and labeled.
(B) V77D and C81D mutants have impaired interaction with NMIIA. S100A4-containing complexes were immunoprecipitated from lysates of nucleofected cells.
Myosin IIA and S100A4 were detected by western blotting. As a control for loading, 5% of the input lysates were run on the gel. See Figure S3 for further
characterization of binding of mutant S100A4.
(C) WT but not mutant S100A4 activates cell migration in transwell assay. Migration rates were expressed as the ratio of the averaged number of migrating cells
relative to the control that was set at 1. Values represent averages of three independent experiments each performed in triplicate. Error bars are SDs among three
independent experiments.
(D) Cell spreading on the collagen-coated micropatterned glass. Nucleofected cells, pBI empty vector (Control), or pBI vector expressing WT or S100A4 mutant
(C81D) were seeded on the collagen type I micropatterned equilateral triangles (length, 41 mm). Cells were stained with antibodies against myosin IIA or S100A4.
(E–G) Analyses were performed using images from 50 cells stained for myosin IIA and S100A4 as in (C). Error bars represent SDs between measurements of
50 cells. *p < 0.05 versus control; **p < 0.005 and ***p < 0.0001. (E) Cell shape analysis. An area of a fully spread cell that adopted the maximum size of the
collagen-coated equilateral triangle micropattern was set at 100% (see Figure S3). (F) Relative area analysis. The area of a spread cell was calculated as
the percent relative to the triangle pattern area, 841 mm. (G) Comparative analysis of the peripheral stress fiber formation. Relative length of the stress fibers
along the cells was measured and plotted against cell perimeter, where the perimeter was set at 100%.
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Structure
Structure of Ca2+-S100A4/Myosin IIA ComplexS100A4 structure and its interaction with Ca2+ (Figures S1I and
S3A–S3D). NMR titration data (Figures S3C and S3D) show
that the KD values are 0.1 mM, corresponding to an increase
by >105 relative to the wild-type (WT). Because the mutations
do not affect the EF2 sites directly but disrupt their simultaneous
engagement, the large reduction in affinity on mutations
demonstrates that the involvement of both sites is crucial for
S100A4/NMIIA interaction. In agreement with our results, C81
was identified recently as a residue critical for the interaction
with NMIIA using modification of the exposed Cys residues
(Dulyaninova et al., 2011).
Having characterized the mutants in vitro, we explored the
effect of these mutations in cells. Both V77D and C81D
S100A4 were expressed in human epithelial carcinoma A431
cells (Andersen et al., 2005) at levels close to theWT (Figure S3E)
but showed no interaction with the intact NMIIA in a coimmuno-
precipitation assay (Figure 3B), similar to the in vitro results.
Expression of the WT S100A4 promoted A431 cell migration in
a transwell assay, but neither of the mutants produced any
effect above the empty vector (Figure 3C). Because the migra-
tion rate is likely to reflect myosin filament stability, we sought
an assay to demonstrate a direct effect of S100A4 on the struc-
ture of NMIIA filaments. Although we could observe an effect
of S100A4 on cell morphology during spreading on uniform
collagen or fibronectin surfaces, we were unable to measure it
reliably because the cell populations were heterogeneous. We,
therefore, used micropatterns as a more controlled way of
attaching cells to surfaces. Spread cells acquire the defined
micropattern shape with a similar distribution of the cytoskeletal
structures within different cells (Picone et al., 2010; The´ry, 2010).
A431 cells were plated on collagen equilateral triangles with
41 mm sides, yielding a total area of 841 mm2 (Figures 3D and
S3G). This size enabled an A431 cell to spread entirely on an
individual micropattern. Control cells or cells expressing
S100A4mutants acquired a triangular shape 90min after plating.
In contrast we observed a collapse of the defined cell borders
in all cells expressing WT S100A4 (Figures 3D–3F, S3F, and
S3G). The observed effect was similar to more extreme changes
in cell phenotype produced by the Rho kinase inhibitor Y27632,
a potent inducer of acto-myosin filament disassembly (Figures
3D–3F, S3F, and S3G) (The´ry, 2010). In agreement with this
observation, staining for NMIIA demonstrated the enrichment
in myosin filaments at the periphery of triangularly shaped
control or C81D mutant-expressing cells (Figure 3G). Here, the
majority of the cells contained large ventral stress fibers marking
the cell perimeter. However, cells overexpressing WT S100A4
showed a reduction in the number of stress fibers, and ventral
stress fibers were either completely absent or less pronounced
than in control or C81D mutant-expressing cells (Figures 3G
and S3G). Previously, Li et al. (2010) reported that S100A4 mildly
increased the presence of NMIIA in the Triton-soluble fraction
of cell lysates prepared from CSF-1-treated macrophages. Our
results are consistent with this observation and, to our knowl-
edge, represent the first microscopic evidence that S100A4
reduces myosin filament assembly in vivo.
S100A4 Interaction with Longer Myosin Fragments
In the whole myosin molecule, S100A4 interacts with the region
initially assembled into the coiled-coil structure. This sequenceStructure 20has a high propensity to form a helical structure. However,
M70 in the complex with S100A4 contains a clear break in the
helical structure at the N terminus of the S100A4-binding site
(Figure S2F). The rational for this is provided by the structure of
the complex. In the complex the N-terminal end of the M39 helix
is in close proximity with the H2-H3 loop of S100A4 that contains
two positively charged residues K48 and R49 (Figure S2G). The
continuation of the myosin helical structure at the N terminus in
the M70 fragment would create a steric clash with the side
chains of these residues. Additionally, the myosin sequence
in this region 1893SRRKL1897 creates a high concentration of
positive charges that repel K48 and R49. These two factors are
expected to destabilize the myosin structure in the complex,
leading to the detected unstructured hinge region. Further
toward the N terminus of M70, the helical structure is reestab-
lished, as expected from the sequence composition. This part
of the molecule is extended beyond the S100A4-binding site
and does not make any contacts with the protein.
The exposed helical region of M70 in the complex is not suffi-
cient for the formation of the coiled-coil structure. However, the
longer fragment M200 (Q1761–E1960) has the required charac-
teristics and forms a stable-coiled coil structure (Badyal et al.,
2011). We carried out single-particle analysis of negatively
stained electron micrographs of the S100A4/M200 complex
(Figure 4). At physiological ionic strength (100 mM Na acetate),
free S100A4 forms dimeric structures, equivalent in size and
shape to the dimeric crystal structure of S100A4, with a length
of 5–6 nm and a width of 3–4 nm (Figures 4A and 4C). In the
presence of M200, the images show a globular structure with
a length of 9–10 nm and awidth of 6–7 nm connected to a thinner
rod (Figures 4D and 4E). Two-dimensional fitting to the average
shape demonstrates that the globular structure has the dimen-
sions corresponding to two S100A4/M39 complexes arranged
in a close proximity, whereas the rod structure has the geomet-
rical characteristics of the NMIIA coiled coil (Figure 4D) and is
similar to that observed for free M200 (Badyal et al., 2011).
This directly demonstrates association of two S100A4 dimers
with the stable coiled-coil myosin fragment, in agreement with
the stoichiometry of the complex determined above. The length
of the coiled-coil region observed in the averaged image is less
than expected for the M200, suggesting some flexibility of
the coiled coil. The orientation of the globular part relative to
the coiled coil shows some variation between the images,
as expected from the disordered structure detected at the
N terminus of the binding site (see above).
DISCUSSION
The asymmetrical 1:2 ligand-binding mode identified here for
the NMIIA/S100A4 complex has strong biological implications.
NMII filaments are formed as the result of staggered packing
of the coiled-coil regions against each other (Figure 5A) stabi-
lized by the matched distribution of positive and negative
charges (McLachlan and Karn, 1982; Atkinson and Stewart,
1992; Ricketson et al., 2010). In vitro studies indicate that
S100A4 can actively dissociate myosin filaments, rather than
just sequester myosin monomers (Badyal et al., 2011). In order
to disassemble filaments, S100A4 interaction with NMII has to
meet specific conditions: (1) high affinity of the interaction; (2), 654–666, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 661
Figure 4. Effect of S100A4 on the Coiled-
Coil Structure of Myosin
(A and B) Negatively stained fields of S100A4
alone and M200/S100A4 complex. Black arrow-
heads and arrows point to individual molecules in
each field.
(C and D) Representative averaged images of
S100A4 alone and M200/S100A4 complex,
respectively. Each averaged image contains 30–
50 images.
(E) Fitting of S100A4 and coiled-coil tail atomic
models to M200/S100A4 averaged image. Left
panel is a selected averaged image of M200/
S100A4 (taken from asterisk-marked average in
D). Middle panel is an equivalent view of assem-
bled atomic models to the average. Right panel is
a superposition of equivalent view of the atomic
model on the average. The lowest-energy struc-
ture of the complex was used to model M39/
S100A4; coiled-coil myosin model was based on
the structure of myosin V (PDB 2DFS). White
arrowheads in the left panel indicate the region of
S100A4 in M200/S100A4 and the emergence of
the M200 densities from the S100A4.
Scale bars apply to the field in (A) and (B) (50 nm)
and averaged images of class images in (C) and (D)
(25 nm).
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Structure of Ca2+-S100A4/Myosin IIA Complexaccessibility of the binding site in the filament; and (3) disruption
of the packing in the filament. The extensive binding interface
of the S100A4/NMIIA complex favors all three conditions.
Our quantitative analysis (Badyal et al., 2011) argued that fila-
ment disassembly requires nanomolar affinity for the interaction
of S100A4 with the monomeric myosin. In the present work we
show that the required affinity originates from the simultaneous
contribution (Jencks, 1981) of the EF2 sites from bothmonomers
of the S100A4 dimer into myosin binding. Notably, most other
interactions reported for S100 proteins involve a single Ca2+-
dependent EF2 site from one subunit and have affinities in the
micromolar range. An apparent exception is the interaction of
S100A10 with AHNAK that has a KD of 167 nM (Rezvanpour
et al., 2011). However, AHNAK only binds to S100A10 that is
already in complex with annexin and is likely to represent
a different configuration of the complex (see above). The data
on the range of S100 complexes suggest that a limited number
of contacts at a single site are not sufficient to generate high-
binding energy required for the disassembly of NMII filaments.
Our conclusion is supported by the recent study of the fused
S100A4 dimer where one binding site was compromised by
mutations (House et al., 2011).
The KD of 1 nM evaluated here for M39 by a range of
methods is significantly lower than reported for both smaller
and larger NMIIA fragments (Ismail et al., 2008; Malashkevich
et al., 2008). Smaller myosin fragments do not include the
full S100A4-binding site and, therefore, have lower affinity
(micromolar to millimolar; Badyal et al., 2011). Longer myosin
fragments form coiled coils, and therefore, part of the binding662 Structure 20, 654–666, April 4, 2012 ª2012 Elsevier Ltd All rights reservedenergy of S100A4 is used to separate
the strands. Furthermore, at physiolog-
ical ionic strength, longer rod fragments(>100 residues) form filamentous aggregates, and this interac-
tion has to be overcome for S100A4 to bind to the monomeric
unit. Hence, although longer fragments contain the complete
binding site, the measured binding constant can be much
weaker than that we observe for M39 (e.g., in the micromolar
region for the intact myosin rod; Ford et al., 1997; Li et al., 2003).
Packing of the NMII filament strongly reduces access of other
proteins to the coiled-coil region. Additionally, the residues from
the coiled-coil part of the binding site that contact S100A4 are
also buried in the coiled-coil interface (Figure 5B). However,
the unstructured C-terminal region of NMIIA is expected to
remain unstructured and dynamic even in the fully formed NMIIA
filament. This region may provide the initial docking site for
S100A4, with the docking facilitated by the proximity of two
S100A4-binding sites in the adjacent strands of the coiled coil.
This suggests a model where the binding proceeds through an
intermediate state in which S100A4 initially interacts with
the unstructured region (Figure 5C). The individual chain of the
coiled-coil part of NMIIA that interacts with S100A4 in the
complex retains its helical structure, and all the hydrophobic
residues that initially formed the coiled-coil interface make
contact with S100A4. We propose an unzipping mechanism
that can facilitate the complex formation. In this mechanism,
S100A4 initially docks weakly to the unstructured region and
then ‘‘rolls over’’ the hydrophobic face of the myosin helix, grad-
ually engaging the rest of the binding site residues, thereby
increasing affinity. In this way the myosin hydrophobic residues
are not exposed to bulk water in the intermediate state, reducing
the entropic barrier of the transition. Immediately upstream of the
Figure 5. S100A4 Interaction with Myosin
Filaments
(A) Schematic diagram of the assembled filament
illustrating staggered packing of myosin units.
(B) Model of the C-terminal region of the myosin
coiled coil (top) and myosin-S100A4 complex
(bottom). Side-chain atoms of the residues in
positions a and d of the heptad repeat that are
crucial for the coiled-coil stability shown as
spheres. Large hydrophobic residues that stabilize
coiled coil are highlighted in blue; nonoptimal
destabilizing residues are in red. S100A4-binding
site in myosin is colored in orange and the rest of
the myosin in gray. S100A4 subunits are shown in
pale green and pale blue. A patch of nonoptimal
residues precedes the S100A4-binding site.
(C) Schematic diagram of the S100A4 interaction
with myosin showing possible intermediates.
Subunits of the S100A4 dimer are shown in red and blue. Initially, S100A4 may interact with the unstructured region that is likely to be accessible in the filaments.
These sites could engage separate S100A4 dimers or simultaneously bind to the two EF2 sites of a single dimer. The binding of the two dimers to the unstructured
region of the coiled coil could be further stabilized by the tetramer formation detected in the crystal structure of S100A4 (Gingras et al., 2008). Potentially, all three
intermediate states could exist in equilibrium.
(D) Sequence comparison of the S100A4-binding site in NMAIIA with the corresponding region in NMAIIB. The residues involved in the direct contact with S100A4
are marked with an asterisk (‘‘*’’). Identical residues are highlighted in orange, similar in green. Chemically distinct residues are shown in black.
Structure
Structure of Ca2+-S100A4/Myosin IIA ComplexS100A4-binding site, the NMIIA sequence contains residues that
destabilize the coiled coil (Figure 5B). This is likely to favor the full
transition into the complex by creating a natural break in the
coiled coil.
Additionally, the myosin helix is destabilized upstream to the
binding site, creating a disorder in the S100A4 orientation rela-
tive to the myosin coiled coil. This disorder is detected by EM,
where distinctly different arrangements are observed (Fig-
ure 4D). Binding of the independent S100A4 dimer to each
chain of the myosin coiled coil increases the disorder in this
region and creates a large bulge that would disrupt the filament
packing.
The high affinity of monomeric NMIIA for S100A4 in the pres-
ence of Ca2+ and the high affinity of the NMIIA-S100A4 for
Ca2+ (required for thermodynamic balance) imply that these
proteins could interact even at resting cytoplasmic Ca2+ concen-
trations (Badyal et al., 2011). However, interactions would be
stronger under conditions of excitation that may be localized
within specific regions of a cell. This property, along with poten-
tial cross-reactivity and degeneracy between both NM and S100
isoforms, complicates investigation of interactions in vivo. We
tested a wide range of support materials for migration and
spreading assays and found that the degree of the effect of
S100A4 expression was strongly dependent on the substrate
type and density; with high-density collagen giving clearest
effect. Additionally, differences in spreading on collagen micro-
patterns in the presence of S100A4 or the binding-deficient
C81D mutant was time dependent (Figure 3). Nevertheless,
A431 cells expressing WT S100A4 consistently showed
a reduced number of stress fibers. We consider that S100A4
becomes involved in the myosin regulation under specific condi-
tions when the Ca2+ concentration and filament stability are
within the optimal range for the interaction. The observed
substrate dependence suggests an interesting possibility that
S100A4 contributes to the feedback mechanism involved in
the detection of the substrate stiffness. If valid this hypothesis
has an implication for the role of S100A4 in metastasis.Structure 20Comparison of NMIIA and IIB sequences shows that the selec-
tivity of S100A4 for NMIIA is associated with the differences in the
C-terminal part of the binding site (Figure 5D). Hydrophobic resi-
dues F1928, V1930, and M1934 that make contacts with S100A4
are replaced by hydrophilic serine residues in NMIIB. These and
neighboring serine residues in NMIIB are phosphorylated by
a-kinases TRMP6 and TRMP7 (Clark et al., 2008), which would
further reduce the interaction with S100A4. The residues in the
coiled-coil region are very similar in the two isoforms and are
expected to make comparable contributions into the binding.
Notably, the previously suggested minimal binding site 1,908–
1,923 (Malashkevichetal., 2008)doesnot include theunstructured
regionandcannot readily explain the isoformselectivityofS100A4.
In summary, our structure of the S100A4/NMIIA complex
shows an asymmetrical binding mode that simultaneously
involves both EF2 sites of the S100A4 dimer. This generates
a high affinity for NMIIA with the KD below 1 nM, unique in the
S100 family of proteins. In the case of S100A4, such a high
affinity is required for the disassembly of myosin filaments. For
the nonfilamentous targets of S100 proteins, nanomolar affinity
may be biologically inappropriate. It remains to be seen if the
S100A4-binding mode has evolved uniquely to match the prop-
erties of NMIIA filaments.
After acceptance of this paper, we became aware of the
results of Kiss et al. (2012), who also investigated the structure
and interaction of a myosin peptide with S100A4 and reached
overall similar conclusions. In order to crystallize the complex,
they introduced four mutations in S100A4, but the conformation
of the bound myosin peptide (PDB 3ZWH) showed only local
differences around the sites of these mutations compared with
our NMR structure.EXPERIMENTAL PROCEDURES
NMR Spectroscopy
For the structural analysis, samples contained 0.8–1 mM of S100A4 in
complex with either M39 or M70 at the stoichiometry 1:2 S100A4:peptide in, 654–666, April 4, 2012 ª2012 Elsevier Ltd All rights reserved 663
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Structure of Ca2+-S100A4/Myosin IIA Complexthe following combinations: u-M39/13C,15N-S100A4, u-M70/13C,15N-S100A4,
and 13C,15N -M70/u-S100A4. The buffer contained 20 mM 4-morpholineetha-
nesulfonic acid (pH 6.1), 20 mM NaCl, 5 mM CaCl2, 4 mM TCEP, 5% (v/v) of
2H2O. Spectra used for the resonance assignments and structure calculations
are detailed in the Supplemental Experimental Procedures.
NMR Structure Calculations
The structure of the complex was calculated with Aria 1.2 in two stages, as fully
described in the Supplemental Experimental Procedures. Briefly, the first
stage was used to generate initial docking model from a subset of intermolec-
ular NOEs with the assignments that can be validated in all the filtered exper-
iments collected for u-M39/13C,15N-S100A4, u-M70/13C,15N-S100A4, and
13C,15N-M70/u-S100A4. In the second stage all intermolecular NOEs assigned
independently were used. In addition all intramolecular NOEs were used at
both stages. For S100A4, intramolecular NOEs were derived from the 3D
NOESY-HSQC spectra of u-M39/13C,15N-S100A4, for M39 from 3D NOESY-
HSQC spectra of 13C,15N-M70/u-S100A4, and 2D filtered NOESY experiment
measured for u-M39/13C,15N-S100A4. Throughout the calculation dihedral
angle restraints and symmetry restraints for N-terminal half of S100A4 (resi-
dues 1–44) were applied. Finally, 200 structures were calculated at each Aria
iteration, 30 best refined in the presence of explicit water molecules, 20
lowest-energy structures used for the analysis and PDB deposition. Statistics
of the structure calculation are presented in Table 1. Ramachandran statistics
for the final ensemble of structures shows that 84.5% of residues are in the
most favorable, 14.4% in allowed, 0.6% in generally allowed, and 0.5% are
in disallowed regions.
Immunoblot Analysis
Cells were lysed in NP-40 buffer (150 mM NaCl, 50 mM Tris [pH 8.0], 0.5%
NP-40, 1 mM dithiothreitol, 10 mM a-glycerophosphate, 50 mM NaF,
0.1 mM Na3VO4, 2 mg/ml aprotinin, 10 mg/ml leupeptin, 1 mM PMSF) for
10 min on ice followed by centrifugation. For immunoprecipitation, proteins
(500 mg) were incubated with 5 mg of anti-S100A4 Mab (DSHB University of
Iowa, Iowa City, IA, USA) overnight. Beads were washed four times, S100A4
complexes were eluted in gel loading buffer and resolved on 6% and 15%
SDS-PAGE gels. Proteins were transferred to PVDF membranes (Millipore)
and stained for S100A4 (Dako, Denmark) or heavy chain of NMIIA (Covance,
Princeton, NJ, USA). To control for protein expression levels, 5% of the input
supernatant was used.
Cell Culture and Assays
A clone of human epithelial carcinoma A431 cells (Andersen et al., 2005) was
used throughout the study. Both V77D and C81D S100A4 were expressed in
S100A4-negative human epithelial carcinoma A431 cells (Andersen et al.,
2005). Cell migrationwas analyzed in a transwell assay according to a standard
protocol with minor modifications (Andersen et al., 2005). Full details are in the
Supplemental Experimental Procedures.
Immunofluorescence Analysis
Cells were cultured on coverslips, rinsed with PBS, fixed in 4% paraformalde-
hyde for 20 min, and permeabilized in 0.5% Triton X-100 for 5 min. Primary
antibodies were anti-S100A4 Mab (DSHB University of Iowa) and polyclonal
anti-heavy chain of NMIIA (Covance). Slides were stained with secondary
anti-mouse 488 Alexa or anti-rabbit 568 Alexa (Invitrogen, Paisley, UK)
antibodies. All antibodies were diluted in DMEM containing 10% FBS. After
counterstaining with DAPI (Molecular Probes), cells were examined and
photographed using a Nikon C1Si confocal laser-scanning microscope
equipped with a CFI Plan Apo 60x, 1.4NA objective lens.
Cell Patterning
Micropatterning, master, and PDMS stamp fabrication were carried out as
described previously (Picone et al., 2010). Micropattern printing is described
in the Supplemental Experimental Procedures. Seventy-two hours after nucle-
ofection, cells were lifted with trypsin (Trypsin-EDTA, PAA), resuspended first
in a small amount of medium with 10% FBS and then diluted in serum-free
medium to a density of 2.5 3 105/ml. A total of 2 ml of suspension was used
for seeding on the micropatterned glass surface. Typically, cells attached to
the printed patterns within 10min of seeding. Nonadherent cells were removed664 Structure 20, 654–666, April 4, 2012 ª2012 Elsevier Ltd All rightsby double washes with PBS. Cells were allowed to attach and spread for
90 min before fixation. For experiments with ROCK inhibitor Y27632 (Sigma-
Aldrich, St. Louis), the inhibitor was added 15 min prior to fixation at a final
concentration of 10 mM. Immunofluorescence analysis was performed as
described above. Micropatterns were stained with anti-collagen type I (clone
COL-1) antibody from Sigma-Aldrich, UK. Image and statistical analyses are
described in the Supplemental Experimental Procedures.
EM and Single-Particle Analysis
For negative staining, purified S100A4 protein was diluted with 100 mM Na
acetate, 0.1 mM CaCl2, 3 mM MgCl2, 10 mM imidazole, 5 mM NaH2PO4
(pH 7.0) (room temperature) to give a final concentration of 400 nM. For visu-
alizing its complex with M200 fragments, purified S100A4 (1mM) and M200
(1 mM) were mixed with the aforementioned dilution buffer then crosslinked
by 0.1% glutaraldehyde for 1 min. The resulting mixture was further diluted
5-fold with the same dilution solution to give a final concentration of 200 nM
of each. A total of 5 ml of each sample preparation was applied to a carbon-
coated grid that had been glow discharged (Harrick Plasma, Ithaca, NY,
USA) for 3 min in air, and the grid was immediately negatively stained using
1% uranyl acetate (Jung et al., 2008). Grids were examined in a Philips
CM120 (FEI, Hillsboro, OR, USA) operated at 80kV, and images were recorded
on a 2K32K F224HD SlowScan CCD camera (TVIPS, Berlin). For single-
particle analysis, images of individual particles on micrographs were selected
interactively, windowed out, and imported into the SPIDER program suite
(Health Research, Rensselaer, NY, USA). Of the particles, 959 (S100A4) and
919 (M200/S100A4 complex) were used in the processing, and class averages
were produced by a reference-free method (Burgess et al., 2004). UCSF
Chimera was used for visualization and comparative analysis between atomic
models and averages (Pettersen et al., 2004).ACCESSION NUMBERS
The coordinates for the structure of M39/S100A4 complex and chemical shifts
have been deposited to PDB, accession code 2LNK. Chemical shifts have
been deposited BRMB accession code 18169.SUPPLEMENTAL INFORMATION
Supplemental Information includes three figures, one table, and Supplemental
Experimental Procedures and can be found with this article online at doi:10.
1016/j.str.2012.02.002.
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